semaglutide vs tirzepatide for Weight Loss Semaglutide vs. Tirzepatide for Weight

Image Credit: Love Employee / Shutterstock In a recent study published in the International Journal of Obesity , researchers assessed the effects of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonists on weight and body composition in adults with overweight or obesity

Conclusion This study provided real-world persistence data for semaglutide QW, and the results of this retrospective, database analysis showed that patients with T2D receiving semaglutide QW had greater persistence than patients receiving dulaglutide, liraglutide, or exenatide QW

The global prevalence of MASLD in adults is approximately 38%

Sip fluids steadily rather than gulping

Obesity [Internet]

Heres the data on what changed, why, and what legitimate options remain